论文部分内容阅读
目的:探析对伴有支原体肺炎患儿予以匹多莫德片治疗的临床效果。方法:选取我院接收诊治的患有小儿支原体肺炎84例患儿为研究资料,依照数字单双号的形式将其分两组,每组42例。实施阿奇霉素治疗对照组,实施匹多莫德片治疗试验组,比较观察试验组和对照组患者的临床治疗效果。结果:73.81%是对照组患儿的治疗有效率,显著低于试验组患者的92.86%(P<0.05);治疗后,试验组患儿的肺部啰音消失时间与肺部炎症吸收时间情况均低于对照组(P<0.05);试验组患儿的IgM、IgG与IgA水平情况均高于对照组(P<0.05)。结论:对小儿支原体肺炎患儿采取匹多莫德片治疗,其治疗效果显著,能使患儿的病症情况得到改善,促进患儿病症恢复。
Objective: To investigate the clinical effect of pidotimod tablets in children with mycoplasma pneumonia. Methods: Eighty-four children with mycoplasma pneumonia admitted for treatment in our hospital were selected as research data and divided into two groups according to the numbers of single and double numbers, with 42 cases in each group. The control group was treated with azithromycin, and the pidotimod treatment group was administered. The clinical effects of the experimental group and the control group were observed. Results: The treatment efficiency was 73.81% in the control group, which was significantly lower than that in the test group (92.86%, P <0.05). After treatment, the pulmonary rales disappeared and the lung inflammation absorption time in the experimental group (P <0.05). The levels of IgM, IgG and IgA in the experimental group were higher than those in the control group (P <0.05). Conclusion: The treatment of children with mycoplasma pneumonia with pidotimod tablets, the treatment effect is significant, can make the child’s condition improved and promote the recovery of children’s illness.